Contact Us

Kathryn St. John
(202) 249-6513

WASHINGTON (October 26, 2016) – The American Chemistry Council (ACC) issued the following statement in response to a paper published in the Journal of Epidemiology & Community Health by Trasande et al. alleging significant European health care costs from exposure to chemicals that the authors have erroneously labeled as endocrine disrupting chemicals (EDCs):

"Once again, Dr. Trasande and his collaborators have ignored both scientific principles and a significant body of research to generate alarmist headlines, create concern, and pressure public officials to disregard the weight of the scientific evidence. Like Dr. Trasande’s other recent publications, this paper falsely claims a direct cause-and-effect relationship between everyday chemicals and specific disease outcomes. And like other recent papers by Dr. Trasande, this publication will certainly be widely criticized and will do nothing to advance scientific understanding of public health.

“ACC strongly supports the U.S. Environmental Protection Agency’s Endocrine Disruptor Screening Program, and we will continue to contribute meaningful, scientifically-validated data to help policymakers make sound decisions about the safety of chemicals in commerce.”

Policy Background: Endocrine Active Chemicals | EndocrineScience.org

News

News & Resources

View our resource center to find press releases, testimonies, infographics and more.

Jobs

Jobs and Economic Impact

The business of chemistry provides 811,000 skilled, good-paying American jobs—earning 44 percent more than the average manufacturing pay.